Nobuyuki Susumu

4.5k total citations
140 papers, 3.1k citations indexed

About

Nobuyuki Susumu is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Molecular Biology. According to data from OpenAlex, Nobuyuki Susumu has authored 140 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Reproductive Medicine, 51 papers in Obstetrics and Gynecology and 46 papers in Molecular Biology. Recurrent topics in Nobuyuki Susumu's work include Endometrial and Cervical Cancer Treatments (49 papers), Ovarian cancer diagnosis and treatment (49 papers) and Genetic factors in colorectal cancer (24 papers). Nobuyuki Susumu is often cited by papers focused on Endometrial and Cervical Cancer Treatments (49 papers), Ovarian cancer diagnosis and treatment (49 papers) and Genetic factors in colorectal cancer (24 papers). Nobuyuki Susumu collaborates with scholars based in Japan, United States and United Kingdom. Nobuyuki Susumu's co-authors include Daisuke Aoki, Akira Hirasawa, Kouji Banno, Hiroyuki Nomura, Wataru Yamagami, Shiro Nozawa, Megumi Yanokura, Yasuhiro Udagawa, Satoru Sagae and Hiroyuki Kuramoto and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Nobuyuki Susumu

137 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuyuki Susumu Japan 32 1.3k 1.1k 1.1k 743 656 140 3.1k
Elisabetta Kuhn Italy 28 594 0.5× 1.2k 1.0× 886 0.8× 496 0.7× 541 0.8× 75 2.5k
Claes G. Tropé Norway 36 928 0.7× 1.2k 1.0× 1.4k 1.3× 787 1.1× 1.2k 1.8× 149 3.8k
Leah Prentice Canada 18 540 0.4× 1.0k 0.9× 909 0.8× 456 0.6× 552 0.8× 26 2.2k
Natália Buza United States 33 870 0.7× 689 0.6× 673 0.6× 325 0.4× 1.2k 1.8× 134 2.9k
Nataliya Melnyk Canada 15 738 0.6× 755 0.7× 898 0.8× 523 0.7× 422 0.6× 18 2.0k
Natalja T. ter Haar Netherlands 26 513 0.4× 436 0.4× 700 0.6× 545 0.7× 677 1.0× 51 2.1k
Tsunehisa Kaku Japan 30 1.3k 1.0× 1.1k 0.9× 512 0.5× 222 0.3× 454 0.7× 107 2.5k
Shoji Kodama Japan 20 900 0.7× 1.5k 1.3× 474 0.4× 233 0.3× 806 1.2× 40 2.6k
Tsui-Lien Mao Taiwan 25 513 0.4× 1.4k 1.2× 2.0k 1.8× 654 0.9× 574 0.9× 31 3.2k
Arto Leminen Finland 28 651 0.5× 590 0.5× 415 0.4× 293 0.4× 538 0.8× 60 1.9k

Countries citing papers authored by Nobuyuki Susumu

Since Specialization
Citations

This map shows the geographic impact of Nobuyuki Susumu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuyuki Susumu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuyuki Susumu more than expected).

Fields of papers citing papers by Nobuyuki Susumu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuyuki Susumu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuyuki Susumu. The network helps show where Nobuyuki Susumu may publish in the future.

Co-authorship network of co-authors of Nobuyuki Susumu

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuyuki Susumu. A scholar is included among the top collaborators of Nobuyuki Susumu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuyuki Susumu. Nobuyuki Susumu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sakai, Kensuke, Miho Kawaida, Tatsuyuki Chiyoda, et al.. (2025). Characteristics of endometrial cancer progressed to extrauterine lesions following fertility preserving medroxyprogesterone acetate therapy for young endometrial cancer patients. Journal of Gynecologic Oncology. 36(6). e104–e104.
2.
Konno, Yosuke, Michinori Mayama, Kazuhiro Takehara, et al.. (2024). Prognostic impact of the number of resected pelvic nodes in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis. Journal of Gynecologic Oncology. 36(1). e3–e3. 1 indexed citations
4.
Arai, Eri, Mao Fujimoto, Ying Tian, et al.. (2022). Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles. Journal of Gynecologic Oncology. 33(6). e74–e74. 5 indexed citations
5.
Yamagami, Wataru, Nobuyuki Susumu, Takeshi Makabe, et al.. (2018). Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?. Journal of Gynecologic Oncology. 29(2). e21–e21. 51 indexed citations
6.
Takehara, Kazuhiro, Natsumi Yamashita, Toru Nakanishi, et al.. (2018). Prognostic factors in patients with uterine leiomyosarcoma: A multiinstitutional retrospective study from the Japanese gynecologic oncology group. Annals of Oncology. 29. viii345–viii345.
7.
Chiyoda, Tatsuyuki, Fumio Kataoka, Hiroyuki Nomura, et al.. (2017). Elevated preoperative neutrophil : lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation. Journal of obstetrics and gynaecology research. 43(4). 744–748. 5 indexed citations
8.
Nogami, Yuya, Yoko Fujii‐Nishimura, Kouji Banno, et al.. (2016). Anisakiasis mimics cancer recurrence: two cases of extragastrointestinal anisakiasis suspected to be recurrence of gynecological cancer on PET-CT and molecular biological investigation. BMC Medical Imaging. 16(1). 31–31. 12 indexed citations
9.
Yokoyama, Yoshihito, Kiyoshi Ito, Kiyoshi Takamatsu, et al.. (2015). How do Japanese gynecologists view hormone replacement therapy for survivors of endometrial cancer? Japanese Gynecologic Oncology Group (JGOG) survey. International Journal of Clinical Oncology. 20(5). 997–1004. 9 indexed citations
10.
Banno, Kouji, Iori Kisu, Megumi Yanokura, et al.. (2012). Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics. Biochemistry Research International. 2012. 1–5. 21 indexed citations
11.
Tsuruta, Tomohiko, Ken‐ichi Kozaki, Atsushi Uesugi, et al.. (2011). miR-152 Is a Tumor Suppressor microRNA That Is Silenced by DNA Hypermethylation in Endometrial Cancer. Cancer Research. 71(20). 6450–6462. 185 indexed citations
12.
Chiyoda, Tatsuyuki, Hiroshi Tsuda, Hideo Tanaka, et al.. (2011). Expression profiles of carcinosarcoma of the uterine corpus—are these similar to carcinoma or sarcoma?. Genes Chromosomes and Cancer. 51(3). 229–239. 37 indexed citations
13.
Yamagami, Wataru, Nobuyuki Susumu, Hideo Tanaka, et al.. (2011). Immunofluorescence-Detected Infiltration of CD4+FOXP3+ Regulatory T Cells is Relevant to the Prognosis of Patients with Endometrial Cancer. International Journal of Gynecological Cancer. 21(9). 1628–1634. 61 indexed citations
14.
Shiozawa, Tanri, Tsutomu Miyamoto, Hiroyasu Kashima, et al.. (2011). Preoperative Differential Diagnosis of Minimal Deviation Adenocarcinoma and Lobular Endocervical Glandular Hyperplasia of the Uterine Cervix. International Journal of Gynecological Cancer. 21(7). 1287–1296. 56 indexed citations
15.
Aoki, Daisuke, Yoh Watanabe, Toshiko Jobo, et al.. (2009). Favourable prognosis with modified dosing of docetaxel and cisplatin in Japanese patients with ovarian cancer.. PubMed. 29(2). 561–6. 5 indexed citations
16.
Banno, Kouji, Megumi Yanokura, Yusuke Kobayashi, et al.. (2009). Endometrial Cancer as a Familial Tumor: Pathology and Molecular Carcinogenesis (Review). Current Genomics. 10(2). 127–132. 16 indexed citations
17.
Banno, Kouji, Nobuyuki Susumu, Takeshi Hirao, et al.. (2003). Identification of germline MSH2 gene mutations in endometrial cancer not fulfilling the new clinical criteria for hereditary nonpolyposis colorectal cancer. Cancer Genetics and Cytogenetics. 146(1). 58–65. 20 indexed citations
18.
Susumu, Nobuyuki, et al.. (2001). Paclitaxel and SN‐38 Overcome Cisplatin Resistance of Ovarian Cancer Cell Lines by Down‐regulating the Influx and Efflux System of Cisplatin. Japanese Journal of Cancer Research. 92(11). 1242–1250. 14 indexed citations
19.
Komiyama, Shinichi, et al.. (1999). Prognosis of Japanese Patients with Ovarian Clear Cell Carcinoma Associated with Pelvic Endometriosis: Clinicopathologic Evaluation. Gynecologic Oncology. 72(3). 342–346. 93 indexed citations
20.
Noguchi, Hiroshi, Kazushige Kiguchi, Daisuke Aoki, et al.. (1993). Human Cervical Epidermal Carcinoma‐associated Intracellular Localization of Glycosphingolipid with Blood Group A Type 3 Chain. Japanese Journal of Cancer Research. 84(6). 664–672. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026